Deguelin
Deguelin, a naturally occurring rotenoid, acts as a chemopreventive agent by blocking multiple pathways like PI3K-Akt, IKK-NF-κB, and MAPK-mTOR-survivin-mediated apoptosis. Deguelin binding to Hsp90 leads to a decreased expression of numerous oncogenic proteins, including MEK1/2, Akt, HIF1α, COX-2, and NF-κB.
Product Specifications
CAS Number
522-17-8
Product Name Alternative
(-) -Deguelin; (-) -cis-Deguelin
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Akt; Apoptosis; Autophagy
Type
Natural Products
Related Pathways
Apoptosis; Autophagy; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/deguelin.html
Purity
99.20
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1[C@]2([H])[C@](COC3=CC(OC)=C(OC)C=C32)([H])OC4=C5C=CC(C)(C)OC5=CC=C14
Molecular Formula
C23H22O6
Molecular Weight
394.42
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral mouse Polg2 shRNA (UAS) - Lentiviral mouse Polg2 shRNA (UAS, GFP) plasmid
Recombinant Mouse Interleukin-1 receptor-associated kinase 4 (Irak4)
Recombinant Mouse Interleukin-1 receptor-associated kinase 4 (Irak4)
Recombinant Mouse Interleukin-1 receptor-associated kinase 4 (Irak4)
Recombinant Mouse Interleukin-1 receptor-associated kinase 4 (Irak4)
